TAM
IART icon

Tiverton Asset Management’s Integra LifeSciences IART Stock Holding History

Tiverton Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$368K Hold
6,126
– – 0.01% 462
2019
Q2 		$342K Sell
6,126
-1,716
-22% -$88.4K 0.01% 478
2019
Q1 		$437K Buy
+7,842
New +$399K 0.02% 367

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Tiverton Asset Management's IART Position: Q3 2019 in Review

Tiverton Asset Management held its Integra LifeSciences (IART) position steady in Q3 2019 at 6,126 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #462.

Tiverton Asset Management first reported a position in IART in Q1 2019 and has held it in 3 quarters since. The position peaked at $437K in Q1 2019. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

  • Tiverton Asset Management held 6,126 shares of Integra LifeSciences worth $368K as of Q3 2019.
  • Tiverton Asset Management left its Integra LifeSciences share count unchanged in Q3 2019.
  • Integra LifeSciences made up 0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #462 holding.
  • Tiverton Asset Management first reported a position in Integra LifeSciences in Q1 2019 and has held it in 3 quarters since.
  • Tiverton Asset Management's Integra LifeSciences position peaked at $437K in Q1 2019.
  • 280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.